Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors.

Y. Y. Wu, M. F. Yen, C. P. Yu, H. H. Chen

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We demonstrated how to comprehensively translate the existing and updated scientific evidence on genomic discovery, tumour phenotype, clinical features, and conventional risk factors in association with breast cancer to facilitate individually tailored screening for breast cancer. We proposed an individual-risk-score-based approach that translates state-of-the-art scientific evidence into the initiators and promoters affecting onset and subsequent progression of breast tumour underpinning a novel multi-variable three-state temporal natural history model. We applied such a quantitative approach to a population-based Taiwanese women periodical screening cohort. Risk prediction for pre-clinical detectable and clinical-detected breast cancer was made by the two risk scores to stratify the underlying population to assess the optimal age to begin screening and the inter-screening interval for each category and to ascertain which high-risk group requires an alternative image technique. The risk-score-based approach significantly reduced the interval cancer rate as a percentage of the expected rate in the absence of screening by 30% and also reduced 8.2% false positive cases compared with triennial universal screening. We developed a novel quantitative approach following the principle of translational research to provide a roadmap with state-of-the-art genomic discovery and clinical parameters to facilitate individually tailored breast cancer screening.

Original languageEnglish
Pages (from-to)2241-2249
Number of pages9
JournalBritish Journal of Cancer
Volume108
Issue number11
DOIs
Publication statusPublished - Jun 11 2013
Externally publishedYes

Fingerprint

Neoplasm Genes
Breast Neoplasms
Phenotype
Neoplasms
Translational Medical Research
Natural History
Early Detection of Cancer
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors. / Wu, Y. Y.; Yen, M. F.; Yu, C. P.; Chen, H. H.

In: British Journal of Cancer, Vol. 108, No. 11, 11.06.2013, p. 2241-2249.

Research output: Contribution to journalArticle

@article{7f69879bd4124fbfbc71871b392fbf03,
title = "Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors.",
abstract = "We demonstrated how to comprehensively translate the existing and updated scientific evidence on genomic discovery, tumour phenotype, clinical features, and conventional risk factors in association with breast cancer to facilitate individually tailored screening for breast cancer. We proposed an individual-risk-score-based approach that translates state-of-the-art scientific evidence into the initiators and promoters affecting onset and subsequent progression of breast tumour underpinning a novel multi-variable three-state temporal natural history model. We applied such a quantitative approach to a population-based Taiwanese women periodical screening cohort. Risk prediction for pre-clinical detectable and clinical-detected breast cancer was made by the two risk scores to stratify the underlying population to assess the optimal age to begin screening and the inter-screening interval for each category and to ascertain which high-risk group requires an alternative image technique. The risk-score-based approach significantly reduced the interval cancer rate as a percentage of the expected rate in the absence of screening by 30{\%} and also reduced 8.2{\%} false positive cases compared with triennial universal screening. We developed a novel quantitative approach following the principle of translational research to provide a roadmap with state-of-the-art genomic discovery and clinical parameters to facilitate individually tailored breast cancer screening.",
author = "Wu, {Y. Y.} and Yen, {M. F.} and Yu, {C. P.} and Chen, {H. H.}",
year = "2013",
month = "6",
day = "11",
doi = "10.1038/bjc.2013.202",
language = "English",
volume = "108",
pages = "2241--2249",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Individually tailored screening of breast cancer with genes, tumour phenotypes, clinical attributes, and conventional risk factors.

AU - Wu, Y. Y.

AU - Yen, M. F.

AU - Yu, C. P.

AU - Chen, H. H.

PY - 2013/6/11

Y1 - 2013/6/11

N2 - We demonstrated how to comprehensively translate the existing and updated scientific evidence on genomic discovery, tumour phenotype, clinical features, and conventional risk factors in association with breast cancer to facilitate individually tailored screening for breast cancer. We proposed an individual-risk-score-based approach that translates state-of-the-art scientific evidence into the initiators and promoters affecting onset and subsequent progression of breast tumour underpinning a novel multi-variable three-state temporal natural history model. We applied such a quantitative approach to a population-based Taiwanese women periodical screening cohort. Risk prediction for pre-clinical detectable and clinical-detected breast cancer was made by the two risk scores to stratify the underlying population to assess the optimal age to begin screening and the inter-screening interval for each category and to ascertain which high-risk group requires an alternative image technique. The risk-score-based approach significantly reduced the interval cancer rate as a percentage of the expected rate in the absence of screening by 30% and also reduced 8.2% false positive cases compared with triennial universal screening. We developed a novel quantitative approach following the principle of translational research to provide a roadmap with state-of-the-art genomic discovery and clinical parameters to facilitate individually tailored breast cancer screening.

AB - We demonstrated how to comprehensively translate the existing and updated scientific evidence on genomic discovery, tumour phenotype, clinical features, and conventional risk factors in association with breast cancer to facilitate individually tailored screening for breast cancer. We proposed an individual-risk-score-based approach that translates state-of-the-art scientific evidence into the initiators and promoters affecting onset and subsequent progression of breast tumour underpinning a novel multi-variable three-state temporal natural history model. We applied such a quantitative approach to a population-based Taiwanese women periodical screening cohort. Risk prediction for pre-clinical detectable and clinical-detected breast cancer was made by the two risk scores to stratify the underlying population to assess the optimal age to begin screening and the inter-screening interval for each category and to ascertain which high-risk group requires an alternative image technique. The risk-score-based approach significantly reduced the interval cancer rate as a percentage of the expected rate in the absence of screening by 30% and also reduced 8.2% false positive cases compared with triennial universal screening. We developed a novel quantitative approach following the principle of translational research to provide a roadmap with state-of-the-art genomic discovery and clinical parameters to facilitate individually tailored breast cancer screening.

UR - http://www.scopus.com/inward/record.url?scp=84884188761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884188761&partnerID=8YFLogxK

U2 - 10.1038/bjc.2013.202

DO - 10.1038/bjc.2013.202

M3 - Article

C2 - 23674086

AN - SCOPUS:84884188761

VL - 108

SP - 2241

EP - 2249

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 11

ER -